Search by Drug Name or NDC

    NDC 00485-0208-16 ED BRON GP 100; 5 mg/5mL; mg/5mL Details

    ED BRON GP 100; 5 mg/5mL; mg/5mL

    ED BRON GP is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by EDWARDS PHARMACEUTICALS, INC.. The primary component is GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00485-0208
    Product ID 0485-0208_43f06e29-011d-4c45-96a2-c15fa4d90bac
    Associated GPIs 43996202100920
    GCN Sequence Number 000702
    GCN Sequence Number Description guaifenesin/phenylephrine HCl LIQUID 100-5 MG/5 ORAL
    HIC3 B4W
    HIC3 Description DECONGESTANT-EXPECTORANT COMBINATIONS
    GCN 54250
    HICL Sequence Number 000250
    HICL Sequence Number Description GUAIFENESIN/PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name ED BRON GP
    Proprietary Name Suffix n/a
    Non-Proprietary Name GUAIFENESIN and PHENYLEPHRINE
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 100; 5
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name EDWARDS PHARMACEUTICALS, INC.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 00485-0208-16 (00485020816)

    NDC Package Code 0485-0208-16
    Billing NDC 00485020816
    Package 473 mL in 1 BOTTLE, PLASTIC (0485-0208-16)
    Marketing Start Date 2012-06-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b1fca5aa-d877-45e0-b074-dcbc6af94ee3 Details

    Revised: 10/2022